Elevated Capital Advisors, LLC

SEC CIK: 0001802387
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

AZN holding history

AstraZeneca PLC in every 13F filed by Elevated Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overview All 13F holders of AZN Full Q2 2026 holdings

Shares (Q2 2026): 39
Value: $7.39K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of AZN by Elevated Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	39	$7.39K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	39	$7.69K	<0.1%	00.0%	UnchangedConverted for a 1-for-2 split	Holders
Q4 2025	78	$7.17K	<0.1%	+78	New	Holders